Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 540

1.

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.

Demissei BG, Hubbard RA, Zhang L, Smith AM, Sheline K, McDonald C, Narayan V, Domchek SM, DeMichele A, Shah P, Clark AS, Fox K, Matro J, Bradbury AR, Knollman H, Getz KD, Armenian SH, Januzzi JL, Tang WHW, Liu P, Ky B.

J Am Heart Assoc. 2020 Jan 21;9(2):e014708. doi: 10.1161/JAHA.119.014708. Epub 2020 Jan 21.

2.

Heart Failure With Preserved Ejection Fraction: Many Emperors With Many Clothes.

Ahmad T, Desai NR, Januzzi JL.

JACC Heart Fail. 2020 Jan 7. pii: S2213-1779(19)30867-4. doi: 10.1016/j.jchf.2019.11.004. [Epub ahead of print] No abstract available.

PMID:
31926855
3.

Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.

Aimo A, Januzzi JL Jr, Vergaro G, Richards AM, Lam CSP, Latini R, Anand IS, Cohn JN, Ueland T, Gullestad L, Aukrust P, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Gamble GD, Ling LH, Leong KTG, Yeo PSD, Ong HY, Jaufeerally F, Ng TP, Troughton R, Doughty RN, Passino C, Emdin M.

Eur J Heart Fail. 2020 Jan 9. doi: 10.1002/ejhf.1701. [Epub ahead of print]

PMID:
31919929
4.

Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery: A Cohort Study.

Duceppe E, Patel A, Chan MTV, Berwanger O, Ackland G, Kavsak PA, Rodseth R, Biccard B, Chow CK, Borges FK, Guyatt G, Pearse R, Sessler DI, Heels-Ansdell D, Kurz A, Wang CY, Szczeklik W, Srinathan S, Garg AX, Pettit S, Sloan EN, Januzzi JL Jr, McQueen M, Buse GL, Mills NL, Zhang L, Sapsford R, Paré G, Walsh M, Whitlock R, Lamy A, Hill S, Thabane L, Yusuf S, Devereaux PJ.

Ann Intern Med. 2019 Dec 24. doi: 10.7326/M19-2501. [Epub ahead of print]

PMID:
31869834
5.

Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.

Butler J, Packer M, Greene SJ, Fiuzat M, Anker SD, Anstrom KJ, Carson PE, Cooper LB, Fonarow GC, Hernandez AF, Januzzi JL Jr, Jessup M, Kalyani RR, Kaul S, Kosiborod M, Lindenfeld J, McGuire DK, Sabatine MS, Solomon SD, Teerlink JR, Vaduganathan M, Yancy CW, Stockbridge N, O'Connor CM.

Circulation. 2019 Dec 17;140(25):2108-2118. doi: 10.1161/CIRCULATIONAHA.119.042155. Epub 2019 Dec 16.

PMID:
31841369
6.

It is time for consistency in the use of biomarkers in heart failure clinical trials.

Januzzi JL Jr, Ibrahim NE.

Eur J Heart Fail. 2019 Dec 3. doi: 10.1002/ejhf.1696. [Epub ahead of print] No abstract available.

PMID:
31797511
7.

Clinical Implications of the New York Heart Association Classification.

Caraballo C, Desai NR, Mulder H, Alhanti B, Wilson FP, Fiuzat M, Felker GM, Piña IL, O'Connor CM, Lindenfeld J, Januzzi JL, Cohen LS, Ahmad T.

J Am Heart Assoc. 2019 Dec 3;8(23):e014240. doi: 10.1161/JAHA.119.014240. Epub 2019 Nov 27.

8.

Preventing and Treating Heart Failure with Sodium-Glucose Co-Transporter 2 Inhibitors.

Vaduganathan M, Januzzi JL Jr.

Am J Cardiol. 2019 Dec 15;124 Suppl 1:S20-S27. doi: 10.1016/j.amjcard.2019.10.026. Review.

PMID:
31741436
9.

Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure.

Alvi RM, Zanni MV, Neilan AM, Hassan MZO, Tariq N, Zhang L, Afshar M, Banerji D, Mulligan CP, Rokicki A, Awadalla M, Januzzi JL, Neilan TG.

Clin Infect Dis. 2019 Sep 28. pii: ciz958. doi: 10.1093/cid/ciz958. [Epub ahead of print]

PMID:
31740919
10.

Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease.

Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, Januzzi JL Jr, Scott NS, Natarajan P.

JAMA. 2019 Nov 18. doi: 10.1001/jama.2019.19191. [Epub ahead of print]

PMID:
31738818
11.

Application of the GRACE, TIMI, and TARRACO Risk Scores in Type 2 Myocardial Infarction.

Murphy S, McCarthy C, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Cui J, Januzzi JL Jr, Wasfy JH.

J Am Coll Cardiol. 2019 Nov 6. pii: S0735-1097(19)38300-7. doi: 10.1016/j.jacc.2019.11.004. [Epub ahead of print] No abstract available.

PMID:
31726195
12.

Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry.

Yang J, Biery DW, Singh A, Divakaran S, DeFilippis EM, Wu WY, Klein J, Hainer J, Ramsis M, Natarajan P, Januzzi JL, Nasir K, Bhatt DL, Di Carli MF, Blankstein R.

Am J Med. 2019 Nov 9. pii: S0002-9343(19)30962-3. doi: 10.1016/j.amjmed.2019.10.020. [Epub ahead of print]

PMID:
31715169
13.

Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week.

Aimo A, Januzzi JL Jr, Bayes-Genis A, Vergaro G, Sciarrone P, Passino C, Emdin M.

J Am Coll Cardiol. 2019 Oct 29;74(17):2193-2203. doi: 10.1016/j.jacc.2019.08.1039. Review.

PMID:
31648713
14.

Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry.

Divakaran S, Singh A, Biery D, Yang J, DeFilippis EM, Collins BL, Ramsis M, Qamar A, Hainer J, Klein J, Cannon CP, Polk DM, Plutzky J, Nasir K, Januzzi JL, Di Carli MF, Bhatt DL, Blankstein R.

Diabetes Care. 2019 Sep 23. pii: dc190998. doi: 10.2337/dc19-0998. [Epub ahead of print]

PMID:
31548242
15.

Are Some Patients With Acute Heart Failure ANP-Deficient?

Richards AM, Januzzi JL Jr.

JACC Heart Fail. 2019 Oct;7(10):899-901. doi: 10.1016/j.jchf.2019.07.003. Epub 2019 Sep 11. No abstract available.

PMID:
31521686
16.

De novo heart failure: where the journey begins.

Myhre PL, Januzzi JL Jr, Butler J, Vaduganathan M.

Eur J Heart Fail. 2019 Oct;21(10):1245-1247. doi: 10.1002/ejhf.1586. Epub 2019 Sep 9. No abstract available.

PMID:
31496006
17.

Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.

Januzzi JL Jr, Prescott MF, Butler J, Felker GM, Maisel AS, McCague K, Camacho A, Piña IL, Rocha RA, Shah AM, Williamson KM, Solomon SD; PROVE-HF Investigators.

JAMA. 2019 Sep 2:1-11. doi: 10.1001/jama.2019.12821. [Epub ahead of print]

PMID:
31475295
18.

Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.

Januzzi JL Jr, Ahmad T, Mulder H, Coles A, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Mark DB, Piña IL, Passmore G, Whellan DJ, Cooper LS, Leifer ES, Desvigne-Nickens P, Felker GM, O'Connor CM.

J Am Coll Cardiol. 2019 Sep 3;74(9):1205-1217. doi: 10.1016/j.jacc.2019.06.055.

PMID:
31466618
19.

A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes.

Mitchell S, Malanda B, Damasceno A, Eckel RH, Gaita D, Kotseva K, Januzzi JL, Mensah G, Plutzky J, Prystupiuk M, Ryden L, Thierer J, Virani SS, Sperling L.

Glob Heart. 2019 Sep;14(3):215-240. doi: 10.1016/j.gheart.2019.07.009. No abstract available.

PMID:
31451236
20.

Phase II Study of Proton Beam Radiation Therapy for Patients With Breast Cancer Requiring Regional Nodal Irradiation.

Jimenez RB, Hickey S, DePauw N, Yeap BY, Batin E, Gadd MA, Specht M, Isakoff SJ, Smith BL, Liao EC, Colwell AS, Ho A, Januzzi JL, Passeri J, Neilan TG, Taghian AG, Lu HM, MacDonald SM.

J Clin Oncol. 2019 Oct 20;37(30):2778-2785. doi: 10.1200/JCO.18.02366. Epub 2019 Aug 26.

PMID:
31449469
21.

Passivating High-Risk Plaques: Try, Try Again.

Januzzi JL Jr, McCarthy CP.

JACC Cardiovasc Imaging. 2019 Aug 8. pii: S1936-878X(19)30556-X. doi: 10.1016/j.jcmg.2019.05.022. [Epub ahead of print] No abstract available.

PMID:
31422122
22.

Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.

Aimo A, Gaggin HK, Barison A, Emdin M, Januzzi JL Jr.

JACC Heart Fail. 2019 Sep;7(9):782-794. doi: 10.1016/j.jchf.2019.06.004. Epub 2019 Aug 7. Review.

PMID:
31401101
23.

Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays: A Practical Approach for Clinicians.

McCarthy CP, Raber I, Chapman AR, Sandoval Y, Apple FS, Mills NL, Januzzi JL Jr.

JAMA Cardiol. 2019 Aug 7. doi: 10.1001/jamacardio.2019.2724. [Epub ahead of print]

PMID:
31389986
24.

2019 Methodology for Creating Expert Consensus Decision Pathways: A Report of the American College of Cardiology.

Januzzi JL Jr, Ahmad T, Binder LG, Hucker WJ, Kumbhani DJ, Maddox TM, Marine JE, Morris PB.

J Am Coll Cardiol. 2019 Aug 27;74(8):1138-1150. doi: 10.1016/j.jacc.2019.05.035. Epub 2019 Jul 23. No abstract available.

PMID:
31350041
25.

Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®.

Ibrahim NE, Song Y, Cannon CP, Doros G, Russo P, Ponirakis A, Alexanian C, Januzzi JL Jr.

ESC Heart Fail. 2019 Aug;6(4):784-792. doi: 10.1002/ehf2.12455. Epub 2019 Jul 3.

26.

Alteration of medical therapy in patients with heart failure relative to change in symptom severity.

Ibrahim NE, Song Y, Cannon CP, Doros G, Russo P, Ponirakis A, Alexanian C, Januzzi JL Jr.

ESC Heart Fail. 2019 Oct;6(5):1085-1087. doi: 10.1002/ehf2.12480. Epub 2019 Jul 3.

27.

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.

Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N, Coats AJS, Metra M, Mebazaa A, Ruschitzka F, Lainscak M, Filippatos G, Seferovic PM, Meijers WC, Bayes-Genis A, Mueller T, Richards M, Januzzi JL Jr; Heart Failure Association of the European Society of Cardiology.

Eur J Heart Fail. 2019 Jun;21(6):715-731. doi: 10.1002/ejhf.1494.

PMID:
31222929
28.

Sex Differences in Patient Characteristics, Treatment Strategies, and Outcomes for Type 2 Myocardial Infarction.

McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL Jr, Wasfy JH.

J Am Coll Cardiol. 2019 Jun 25;73(24):3230-3232. doi: 10.1016/j.jacc.2019.04.016. No abstract available.

PMID:
31221266
29.

Performance of a clinical/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes mellitus.

McCarthy CP, Shrestha S, Ibrahim N, van Kimmenade RRJ, Gaggin HK, Mukai R, Magaret C, Barnes G, Rhyne R, Garasic JM, Januzzi JL.

Open Heart. 2019 May 13;6(1):e000955. doi: 10.1136/openhrt-2018-000955. eCollection 2019.

30.

Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.

Aimo A, Januzzi JL Jr, Mueller C, Mirò O, Pascual Figal DA, Jacob J, Herrero-Puente P, Llorens P, Wussler D, Kozhuharov N, Sabti Z, Breidthardt T, Vergaro G, Ripoli A, Prontera C, Saccaro L, Passino C, Emdin M.

Int J Cardiol. 2019 Oct 15;293:137-142. doi: 10.1016/j.ijcard.2019.06.005. Epub 2019 Jun 4.

PMID:
31200964
31.

Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome.

Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Emdin M.

Eur J Prev Cardiol. 2019 Nov;26(16):1751-1759. doi: 10.1177/2047487319852809. Epub 2019 Jun 1.

PMID:
31154828
32.

Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.

Singh A, Gupta A, Collins BL, Qamar A, Monda KL, Biery D, Lopez JAG, de Ferranti SD, Plutzky J, Cannon CP, Januzzi JL Jr, Di Carli MF, Nasir K, Bhatt DL, Blankstein R.

J Am Coll Cardiol. 2019 May 21;73(19):2439-2450. doi: 10.1016/j.jacc.2019.02.059.

PMID:
31097165
33.

Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.

Natarajan P, Collier TS, Jin Z, Lyass A, Li Y, Ibrahim NE, Mukai R, McCarthy CP, Massaro JM, D'Agostino RB Sr, Gaggin HK, Bystrom C, Penn MS, Januzzi JL Jr.

J Am Coll Cardiol. 2019 May 7;73(17):2135-2145. doi: 10.1016/j.jacc.2019.01.073.

PMID:
31047001
34.

Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program.

McCarthy CP, Vaduganathan M, Patel KV, Lalani HS, Ayers C, Bhatt DL, Januzzi JL Jr, de Lemos JA, Yancy C, Fonarow GC, Pandey A.

JAMA Netw Open. 2019 Apr 5;2(4):e192987. doi: 10.1001/jamanetworkopen.2019.2987.

35.

Reply: hs-cTnI in Stable Chest Pain.

Januzzi JL Jr, Ginsburg GS, Douglas PS.

J Am Coll Cardiol. 2019 Apr 30;73(16):2121-2122. doi: 10.1016/j.jacc.2019.02.050. No abstract available.

PMID:
31023439
36.

Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction.

Asensio-Lopez MC, Lax A, Fernandez Del Palacio MJ, Sassi Y, Hajjar RJ, Januzzi JL, Bayes-Genis A, Pascual-Figal DA.

J Mol Cell Cardiol. 2019 May;130:216-233. doi: 10.1016/j.yjmcc.2019.04.009. Epub 2019 Apr 15.

PMID:
30998979
37.

Usefulness of a Positive Psychology-Motivational Interviewing Intervention to Promote Positive Affect and Physical Activity After an Acute Coronary Syndrome.

Huffman JC, Feig EH, Millstein RA, Freedman M, Healy BC, Chung WJ, Amonoo HL, Malloy L, Slawsby E, Januzzi JL, Celano CM.

Am J Cardiol. 2019 Jun 15;123(12):1906-1914. doi: 10.1016/j.amjcard.2019.03.023. Epub 2019 Mar 19.

PMID:
30979409
38.

Race/ethnicity and plasma NT-proBNP in black and white individuals: How it matters.

Emdin M, Aimo A, Clerico A, Januzzi JL.

Int J Cardiol. 2019 Jul 1;286:164-165. doi: 10.1016/j.ijcard.2019.03.032. Epub 2019 Mar 22. No abstract available.

PMID:
30948217
39.

Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry.

Jogu HR, Arora S, Vaduganathan M, Qamar A, Pandey A, Chevli PA, Pansuriya TH, Ahmad MI, Dutta A, Sunkara PR, Qureshi W, Vasu S, Upadhya B, Bhatt DL, Januzzi JL Jr, Herrington D.

Clin Cardiol. 2019 Jun;42(6):592-604. doi: 10.1002/clc.23182. Epub 2019 Apr 12.

40.

Requiem for a Heavyweight: Ejection Fraction as a Prognostic Biomarker.

Januzzi JL Jr.

JACC Heart Fail. 2019 Apr;7(4):318-320. doi: 10.1016/j.jchf.2019.02.002. No abstract available.

PMID:
30922508
41.

Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists.

Vaduganathan M, Patel RB, Singh A, McCarthy CP, Qamar A, Januzzi JL Jr, Scirica BM, Butler J, Cannon CP, Bhatt DL.

J Am Coll Cardiol. 2019 Apr 2;73(12):1596-1598. doi: 10.1016/j.jacc.2019.01.029. No abstract available.

PMID:
30922481
42.

Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.

O'Connor C, Fiuzat M, Mulder H, Coles A, Ahmad T, Ezekowitz JA, Adams KF, Piña IL, Anstrom KJ, Cooper LS, Mark DB, Whellan DJ, Januzzi JL Jr, Leifer ES, Felker GM.

Eur J Heart Fail. 2019 Jun;21(6):770-778. doi: 10.1002/ejhf.1450. Epub 2019 Mar 27.

PMID:
30919549
43.

Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.

Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Szymonifka J, Apple FS, Burnett JC Jr, Iyer S, Januzzi JL Jr.

J Am Coll Cardiol. 2019 Mar 26;73(11):1273-1284. doi: 10.1016/j.jacc.2018.12.063.

PMID:
30898202
44.

Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs.

McCarthy C, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL Jr, Wasfy JH.

JAMA Cardiol. 2019 May 1;4(5):460-464. doi: 10.1001/jamacardio.2019.0716.

PMID:
30879022
45.

Underutilization of Cardiac Rehabilitation for Type 2 Myocardial Infarction.

McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL Jr, Wasfy JH.

J Am Coll Cardiol. 2019 Apr 23;73(15):2005-2007. doi: 10.1016/j.jacc.2019.01.032. Epub 2019 Mar 4. No abstract available.

PMID:
30846342
46.

Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes.

McCarthy CP, Murphy S, Venkateswaran RV, Singh A, Chang LL, Joice MG, Rivero JM, Vaduganathan M, Januzzi JL Jr, Bhatt DL.

J Am Coll Cardiol. 2019 Apr 23;73(15):2007-2009. doi: 10.1016/j.jacc.2019.01.031. Epub 2019 Mar 4. No abstract available.

PMID:
30846340
47.

Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel.

Januzzi JL Jr, Mahler SA, Christenson RH, Rymer J, Newby LK, Body R, Morrow DA, Jaffe AS.

J Am Coll Cardiol. 2019 Mar 12;73(9):1059-1077. doi: 10.1016/j.jacc.2018.12.046. Epub 2019 Feb 21. Review.

PMID:
30798981
48.

Implementation of an Emergency Department High-Sensitivity Troponin Chest Pain Pathway in the United States.

Baugh CW, Scirica BM, Januzzi JL, Morrow DA, Lewandrowski KB, Jarolim P, White BA, Weinfeld MS, Hoffmann U, Nagurney JT.

Crit Pathw Cardiol. 2019 Mar;18(1):1-4. doi: 10.1097/HPC.0000000000000164. No abstract available.

PMID:
30747757
49.

Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain.

Januzzi JL Jr, Suchindran S, Hoffmann U, Patel MR, Ferencik M, Coles A, Tardif JC, Ginsburg GS, Douglas PS; PROMISE Investigators.

J Am Coll Cardiol. 2019 Jan 29;73(3):251-260. doi: 10.1016/j.jacc.2018.10.065.

50.

Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study.

Ibrahim NE, McCarthy CP, Shrestha S, Lyass A, Li Y, Gaggin HK, Simon ML, Massaro JM, D'Agostino RB Sr, Garasic JM, van Kimmenade RR, Januzzi JL Jr.

Am Heart J. 2019 Mar;209:36-46. doi: 10.1016/j.ahj.2018.12.001. Epub 2018 Dec 7.

PMID:
30641399

Supplemental Content

Loading ...
Support Center